Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments. Of the 88 patients included, 72 developed any kind of immune response after vacc...

Full description

Bibliographic Details
Main Authors: Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, José Vivancos, Francisco Sanchez-Madrid, Arantzazu Alfranca
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Clinical Immunology Communications
Online Access:http://www.sciencedirect.com/science/article/pii/S277261342300001X

Internet

http://www.sciencedirect.com/science/article/pii/S277261342300001X

Similar Items